Work

Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

Year: 2016

Type: letter

Abstract: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer No conflict of interest declared.

Source: Archivio Italiano di Urologia e Andrologia

DOI: 10.4081/aiua.2016.1.72

Authors: Johann De Bono, Liji Shen, Oliver Sartor

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Sanofi (United States), Tulane University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $323

Funder: Sanofi

OpenAlex ID: W2339686852

Cites: 2

Cited by: 1

Related to: 10